217
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Management of Malignant Chylothorax with Subcutaneous Octreotide Treatment

Pages 48-51 | Received 28 May 2020, Accepted 22 Jan 2021, Published online: 18 Feb 2021

References

  • Bibby AC, Maskell NA. Nutritional management in chyle leaks and chylous effusions. Br J Community Nurs. 2014:S6–S8. doi:10.12968/bjcn.2014.19.Sup11.S6. Cited in: PMID: 25381927.
  • Pospiskova J, Smolej L, Belada D, Simkovic M, Motyckova M, Sykorova A, Stepankova P, Zak P. Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders. Orphanet J Rare Dis. 2019;14(1):9. doi:10.1186/s13023-018-0991-3. Cited in: PMID: 30626415.
  • Schild H, Strassburg CP, Welz A, Kalff J. Treatment options in patients with chylothorax. Dtsch Arztebl Int. 2013;110(48):819–26. doi:10.3238/arztebl.2013.0819.
  • Mincher L, Evans J, Jenner MW, Varney VA. The successful treatment of chylous effusions in malignant disease with octreotide. Clin Oncol (R Coll Radiol)). 2005;17(2):118–21. doi:10.1016/j.clon.2004.06.016. Cited in: PMID: 15830574.
  • ODonnell J, Kirkham J. Chylous cardiac tapenade with chylothoracies secondary to Hodgkin's lymphoma: the first recorded case of successful octreotide treatment. Am J Respir Crit Care Med. 2019;199:A6422–A6422. doi:10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A6422.
  • Gupta A, Singh T. Octreotide in malignant chylothorax: a case report. BMJ Support Palliat Care. 2016;6(1):122–4. doi:10.1136/bmjspcare-2015-000933. Cited in: PMID: 26644224.
  • Zhao D, Sadoughi A. Refractory bilateral chylothorax, a challenging case [abstract]. In: American Thoracic Society 2019 International Conference; Dallas, TX. New York, NY: American Thoracic Society Journals:A4681, May 19, 2019.
  • Ye F, Srour K, Saleh H, Saidahmed T, Khateeb FM, Safi F. An extremely rare case of transudate chylothorax secondary to carcinoid tumor [abstract]. In: American Thoracic Society 2018 International Conference; San Diego, CA. New York, NY: American Thoracic Society Journals; 2018:A4074. May 21.
  • Novartis Pharmaceuticals Canada Inc. SANDOSTATIN® and SANDOSTATIN® LAR® product monograph. Dorval, Quebec; 22 January 2020.
  • Lou B, Khanijo S, Habibullah JM. Spilled milk: a case of diffuse chylous effusions. Am J Respir Crit Care Med. 2020;201:A6431.
  • Kilic D, Sahin E, Gulcan O, Bolat B, Turkoz R, Hatipoglu A. Octreotide for treating chylothorax after cardiac surgery. Tex Heart Inst J. 2005;32(3):437–9.
  • Rimensberger PC, Muller-Schenker B, Kalangos A, Beghetti M. Treatment of persistent post-operative chylothorax with somatostatin. Ann Thorac Surg. 1998;66(1):253–4. Cited in: PMID: 9692478. doi:10.1016/S0003-4975(98)00361-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.